54 min ago
What Does a Multibillion-Dollar Corporation Want With Crowdfunding?
As of this morning, consumer products giant Johnson & Johnson was worth almost $300 billion.
5 hrs ago
The Jersey Journal
Man found dead near New Brunswick train station had belt around neck, police say
NEW BRUNSWICK - A 36-year-old man whose decomposed body was found near the city train station a week after he was reported missing apparently committed suicide near the station, according to a recently released police report.
Thu Jul 31, 2014
Johnson & Johnson pulls hysterectomy tool tied to cancer risk from market
The largest maker of a surgical tool that has shown an increased risk of spreading undetected cancers in women has said it will withdraw its device from the market.
Cinema verite pioneer Robert Drew dies
JOHNSON & Johnson is pulling its fibroid treatment devices worldwide following concerns it could spread cancer to other parts of the body.
Codman Neuro introduces new ENVOY Guiding Catheters for neurovascular procedures
Codman Neuro, part of DePuy Synthes Companies of Johnson & Johnson, announced the launch of the ENVOY DA XB Distal Access Guiding Catheter and the 7F ENVOY Guiding Catheter for neurovascular procedures.
Johnson & Johnson recalls power morcellators
A surgical device maker on Wednesday issued a voluntary worldwide recall of its products because of the risk of spreading undetected cancer.
Wed Jul 30, 2014
J&J seeks return of device seen as possibly raising cancer risk
Johnson & Johnson said on Wednesday it plans to ask doctors to return its power morcellators, a controversial surgical device that may inadvertently spread cancer in women being treated for uterine growths called fibroids.
Dendreon appoints retired Johnson & Johnson exec as new CEO
Seattle cancer drug-maker Dendreon has named 71-year-old retired biotech executive W. Thomas Amick as the company's new CEO.
J&J And Organovo Link For 3D-Printing Drug Discovery
Johnson & Johnson company Janssen Research and Development announced that it is has entered into collaboration with bioprinting firm Organovo to investigate 3D printing of living tissue for drug discovery and research.
Tue Jul 29, 2014
IBM board adds Johnson & Johnson CEO, former Royal Dutch Shell CEO
Closing out a month that included a landmark deal with Apple, IBM is boosting its board of directors with two new additions who are seasoned chief executives.
Sun Jul 27, 2014
High valuations put on older generics
Mumbai, July 27: GlaxoSmithKline Plc is likely to receive a good response if it indeed puts up its older but off-patented drugs for sale, given the massive gain Bafna Pharma made from Raricap.
Tue Jul 22, 2014
Johnson & Johnson board approved $5B stock buyback plan
Johnson & Johnson's board of directors approved a plan for the New Jersey health-care company to repurchase up to $5 billion of its common stock.
The Jersey Journal
Johnson & Johnson volunteers support Buck Garden in Far Hills
Johnson & Johnson 'Day of Caring' volunteers descended upon Somerset County Park Commission Leonard J. Buck Garden at 11 Layton Road in Far Hills.
Thu Jul 17, 2014
Johnson & Johnson Spinout Zosano Pharma, Inc. Sets Terms For $70 Million IPO
Zosano Pharma, a biotech developing a transdermal delivery system to treat osteoporosis, announced terms for its IPO on Wednesday.
Wed Jul 16, 2014
Three Documentary Films All Progressives Should See, Learn & Memorize
As part of another diary I brought up several excellent sources of Truth, Reality and Knowledge and today I re-post that information purely for it's own sake because I truly believe - it's worth the effort and benefit that it may impart to all those who are willing to listen and capable of comprehending the message.
Wall St. Cheat Sheet
Does Johnson & Johnson Belong in Your Portfolio?
The company operates in three segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics.
Tue Jul 15, 2014
UPDATE 3-J&J beats forecasts, helped by new hepatitis C drug
Johnson & Johnson reported higher-than-expected quarterly results on sizzling sales of its new Olysio treatment for hepatitis C, but company officials cautioned the pill will lose steam later this year as newer rivals come to market.
Customer Interaction Solutions
Medivir: Continued strong market uptake for OLYSIO during the second quarter 2014
Medivir AB announces that the global second quarter net sales of Olysio amounted to 831 MUSD, of which 725 MUSD were sales in the USA.
Johnson & Johnson (JNJ) Falls Despite Earnings Beat, Strong Olysio Sales
Your browser is not supported. Please upgrade to one of the following browsers: Google Chrome Mozilla Firefox Apple Safari Microsoft Internet Explorer 8+ You may proceed to the site by clicking here , however some pages might not work correctly.
The Modesto Bee
Stock futures edge up following mixed retail data
Stock futures edged higher Tuesday as investors digested mixed U.S. retail sales data and several corporate earnings reports.